NCT01023100

Brief Summary

This study will test the palatability of several different CP-690,550 oral preparations in trained product tester healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2009

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 2, 2009

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

June 16, 2010

Status Verified

June 1, 2010

Enrollment Period

Same day

First QC Date

November 25, 2009

Last Update Submit

June 14, 2010

Conditions

Arthritis, Rheumatoid

Keywords

taste study open label investigational drug oral therapy

Outcome Measures

Primary Outcomes (1)

  • A complete description of the sensory attributes of products (eg, aroma, flavor, texture, and mouthfeel).

    3 months

Study Arms (1)

Open label

EXPERIMENTAL
Drug: CP 690,550 oral solutions

Interventions

CP 690,550 oral solutionsDRUG

flavored and unflavored prototype CP-690,550 formulations

Open label

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Trained healthy non-pregnant product testers, age 18-75

You may not qualify if:

  • Severe acute or chronic medical conditions, including hepatitis or tuberculosis infections or clinically significant laboratory abnormalities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pfizer Investigational Site

Woburn, Massachusetts, 01801, United States

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 25, 2009

First Posted

December 2, 2009

Study Start

March 1, 2010

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

June 16, 2010

Record last verified: 2010-06

Locations

US(1)